Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

High materiality9/10

Clorox lowers guidance amid mixed Q3 results and executive outlook

Apr 30, 2026, 5:31 PM EDT2 sourcesAI-analyzed

Why it may matterVerify against the original reporting

Lowered guidance and declining sales raise concerns about Clorox's operational strength and future profitability, likely pressuring the stock price.

AI summary

What happened, with direct paths to the underlying reporting

Clorox has reported mixed Q3 results, with flat revenue but a 1% decline in organic sales. The company adjusted its EPS guidance downwards and projects a 6% revenue decline in fiscal 2026, impacting investor sentiment as shares approach a new 52-week low.

Clorox's Q3 revenue stable, but organic sales dropped 1%.
Adjusted EPS guidance lowered from $5.95-$6.30 to $5.45-$5.65.
Net sales projected to decline 6% in fiscal 2026.
International sales increased by 8%, boosting overall performance.
Stock down 6.4%, nearing a new 52-week low.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.

Clorox lowers guidance amid mixed Q3 results and executive outlook

Clorox Guides Above-Consensus Sales on Health and International Demand

Clorox Q4 earnings due Aug 3; earnings decline and dividend increase expected

Clorox climbs on COO appointment; 5% yield supports income-focused buyers

Clorox lowers profit outlook amid rising costs and weak demand